Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2024 May 19;35(2):102213. doi: 10.1016/j.omtn.2024.102213

Retraction Notice to: Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression

Zhao Zhao, Mei Ji , Qianqing Wang, Nannan He, Yue Li
PMCID: PMC11111817  PMID: 38784178

Main text

(Molecular Therapy: Nucleic Acids 18, 24–33; December 2019)

This article has been retracted at the request of the editor-in-chief. Concerns regarding image recycling were posted to a Pubpeer thread (https://pubpeer.com/publications/10EAFBD7B0DF163E80A7EAB0807F8B). Similarities were found between images in this article and articles published by different authors in Oncotarget (Shen et al., 2017, Oncotarget 8, 14479–1448, https://doi.org/10.18632/oncotarget.10407) and in this same journal, Molecular Therapy Nucleic Acids (Feng et al. 2019, Mol. Ther. Nucleic Acids 18, 375–387, https://doi.org/10.1016/j.omtn.2019.08.024). Image analysis performed by the editorial office confirmed the findings of image reuse with Figures 2C and 2D. This reuse of data without appropriate attribution represents a severe abuse of the scientific publishing system. The notice of retraction was undeliverable to all authors except for the corresponding author. No response was received from the corresponding author.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES